Sign inJoin waitlistJoin the waitlist

Peter Noseworthy

Medical Director, Department of Business Development · Mayo Clinic College of Medicine and Science

Credentials: · · · · · · · ·

History

Department of Business Development · Mayo Clinic College of Medicine and Science
Present
Division of Heart Rhythm Services Department · Mayo Clinic College of Medicine and Science
Present
Harvard School of Public Health
Present

Fellow in Cardiac Electrophysiology Massachusetts General Hospital
2010–2012
Clinical Fellow in Cardiology Massachusetts General Hospital and Harvard Medical School
2007–2010
Internal Medicine Massachusetts General Hospital and Harvard Medical School
2004–2007
University of Toronto
2000–2004

Research

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized…
JAMA · 2019 · 1,197 citations
An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction
The Lancet · 2019 · 1,062 citations
Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram
Nature Medicine · 2019 · 914 citations

Paul Friedman
159 papers
Samuel Asirvatham
88 papers
Konstantinos Siontis
81 papers · 56 as a resident
Suraj Kapa
63 papers · 17 as a fellow
Abhishek Deshmukh
60 papers · 12 as a fellow
BG
Bernard Gersh
60 papers
Francisco Lopez-Jimenez
59 papers
Anthony Kashou
56 papers · 56 as a resident
Michael Ackerman
42 papers
Christopher DeSimone
36 papers · 24 as a resident
Siva Mulpuru
33 papers · 14 as a fellow
Adam May
32 papers · 12 as a fellow

Grants

Optimizing Stroke Prevention for Older Adults with Atrial Fibrillation: Towards Rigorous Evaluation and Judicious Application of a New Device
National Institute on Aging · R01
Contact PI · $2.5M · Mayo Clinic Rochester
2020–2026
Pairing Observational and Patient-Level Clinical Trial Data to Assess Cardiovascular Risk Reduction with Catheter Ablation for Atrial Fibrillation
National Heart, Lung, and Blood Institute · R21
PI · $255.6K · Mayo Clinic Rochester
2017–2020

Clinical trials

A Multi-Center Study of Detection of Low Ventricular Ejection Fraction
Principal investigator · Completed
Mayo Clinic
2021–2022
Heart Watch Study: a Pragmatic Randomized Controlled Trial
Principal investigator · Completed
Yale University
2021–2024
Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF
Principal investigator · Completed
Mayo Clinic
2020–2022
ECG AI-Guided Screening for Low Ejection Fraction
Principal investigator · Completed
Mayo Clinic
2019–2020